spacer
home > white papers > The Use of Stainless Steel Equipment Within Laboratories and Clean Rooms - Teknomek Ltd
WHITE PAPERS
logo_Teknomek_Le.jpg

Teknomek Ltd

phone +44 (0)1603 788 833
email mail@teknomek.co.uk
web http://www.teknomek.co.uk
email Brunel Way, Sweetbriar Industrial Estate, Norwich, Norfolk NR3 2BD

The Use of Stainless Steel Equipment Within Laboratories and Clean Rooms

Teknomek explains why stainless steel is the material of choice for laboratories and hygienic manufacturing.

Clean and safe environments are essential criteria for compliance with UK Medicines and Healthcare products Regulatory Agency (MHRA) regulations.  To support this, furniture and equipment must facilitate Good Manufacturing Practice (GMP) by withstanding thorough cleaning and maintenance.

Stainless steel furniture and equipment helps businesses to meet the stringent hygiene audits set by the MHRA.  The material is incredibly versatile when it comes to design, plus is robust enough to withstand the most rigorous of cleaning processes.  It is common practice for stainless steel furniture providers to work very closely with their customers to deliver tailor-made solutions that comply with regulatory criteria...

Download this white paper to find out more.
spacer

Member login

E-mail address:

Password:
Remember me


News and Press Releases

Innovative Micro-Infusion Pump for Gerresheimer Subsidiary Sensile Medical Developed and Successfully Launched for EVER Pharma

Düsseldorf/Olten, July 03, 2019 – Developed specially by Sensile Medical for EVER Pharma under the brand name D-mine®, this wearable microinfusion pump recently received European CE certification and has already been launched in several European countries. The compact, patient-friendly infusion pump is used for the continuous subcutaneous administration of drugs to treat Parkinson’s disease. The first micro pump from Gerresheimer subsidiary Sensile Medical to be available on the market, it gives Parkinson’s patients greater independence in their day-today lives.
More info >>


White Papers

Analysis of Biopharmaceuticals to Conform to ICHQ6B

RSSL

Worldwide, the pharmaceuticals market is anticipated to grow from more than USD 782 billion in 2011 to approach a value of just over USD 971 billion by the end of 2016, registering a CAGR of over 24%. In 2010 the average medicines expenditure per person within the UK was £271, and this is expected to increase with the ageing population. A significant and increasing proportion of these sales are protein-based biotherapeutics or biomolecules. Currently, these account for 19% of the total market, and are growing at twice the rate of traditional small molecule pharmaceuticals. It is predicted that close to 50% of the top 100 pharmaceutical products will be biomolecules by 2016. By far the largest segment of the biopharmaceutical market is the monoclonal antibody (MAb) with an estimated share of 25.6%, which corresponds to USD 51.1 billion.
More info >>


Industry Events

ELRIG Drug Discovery 2019 – Looking Back to the Future

5-6 November 2019, ACC, Liverpool

Now in its 13th year, ELRIG’s flagship conference Drug Discovery 2019 will take place at ACC in Liverpool. This year’s focus, ‘A Look Back to the Future’ is planned to include plenary introductions assessing how we got to where we are now and setting the challenges for discovering the drugs of the future. These will be followed by cutting edge talks and examples of new directions in drug discovery. Our scientific programme will feature over 40 world-class speakers with 6 main session tracks. In partnership with key academic and charitable groups, we will also run joint disease and biology-oriented tracks focusing on the basic sciences that underpin successful drug discovery.
More info >>


©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement